These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8886506)

  • 1. Peripheral vasculature in essential hypertension.
    Mulvany MJ
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S6-10. PubMed ID: 8886506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients.
    Mulvany MJ
    Metabolism; 1998 Dec; 47(12 Suppl 1):20-3. PubMed ID: 9867066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease.
    Mulvany MJ
    J Hum Hypertens; 1995 Jun; 9(6):479-85. PubMed ID: 7473531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibition on vascular remodelling of resistance vessels in hypertensive patients.
    Mulvany MJ
    J Hypertens Suppl; 1996 Dec; 14(6):S21-4. PubMed ID: 9023711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure?
    Christensen HR; Nielsen H; Christensen KL; Baandrup U; Jespersen LT; Mulvany MJ
    J Hypertens Suppl; 1988 Dec; 6(3):S27-31. PubMed ID: 3225687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodelling in hypertension.
    Mulvany MJ
    Eur Heart J; 1993 Jul; 14 Suppl C():2-4. PubMed ID: 8365424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are vascular abnormalities a primary cause or secondary consequence of hypertension?
    Mulvany MJ
    Hypertension; 1991 Sep; 18(3 Suppl):I52-7. PubMed ID: 1889858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling of resistance vessel structure in essential hypertension.
    Mulvany MJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):77-81. PubMed ID: 7922171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Blood Press; 1995 Jul; 4(4):241-8. PubMed ID: 7496564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure.
    Mulvany MJ; Persson AE; Andresen J
    J Hypertens; 1991 Jul; 9(7):589-93. PubMed ID: 1653793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N; Head GA
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Am J Cardiol; 1995 Nov; 76(15):38E-40E. PubMed ID: 7484887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent effects of perindopril on blood pressure and small-artery structure.
    Thybo NK; Korsgaard N; Eriksen S; Christensen KL; Mulvany MJ
    Hypertension; 1994 May; 23(5):659-66. PubMed ID: 8175177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of resistance vessel structure in essential hypertension: are these important?
    Mulvany MJ
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):13-20. PubMed ID: 2032384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical and other factors involved in vascular injury related to hypertension.
    Mulvany MJ
    Blood Press Suppl; 1994; 1():11-7. PubMed ID: 8205292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.